Alnylam Pharmaceuticals | ALNY - المدينين التجاريين





المدينين التجاريين تغيير تاريخ
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 1.08B 172.17M 2026-09
Amgen USD 10.35B 126M 2026-09
Arrowhead Research USD 8.56M 7.13M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
BioMarin Pharmaceutical USD 1.08B 15.31M 2026-09
Incyte USD 1.24B 111.82M 2026-09
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Moderna USD 17M 54M 2026-06
Neurocrine Biosciences USD 957.3M 70.3M 2026-09
Novartis USD 9.96B 361M 2026-09
PTC Therapeutics USD 239.04M 19.12M 2026-06
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 492M 10M 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
Takeda JPY 910.24B 45.9B 2026-09
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 200M 140M 2026-06
Vertex Pharmaceuticals USD 2.31B 176.7M 2026-09
Xencor USD 42.23M 30.23M 2026-06